Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 10.38 million shares were traded. HIVE stock price reached its highest trading level at $2.885 during the session, while it also had its lowest trading level at $2.81.
Ratios:
To gain a deeper understanding of HIVE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.56 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 19, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $7.50.
On October 29, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $9.Cantor Fitzgerald initiated its Overweight rating on October 29, 2024, with a $9 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIVE now has a Market Capitalization of 365497312 and an Enterprise Value of 331784992. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.97 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 2.697 whereas that against EBITDA is 12.492.
Stock Price History:
The Beta on a monthly basis for HIVE is 4.47, which has changed by -0.21823204 over the last 52 weeks, in comparison to a change of 0.21659255 over the same period for the S&P500. Over the past 52 weeks, HIVE has reached a high of $5.54, while it has fallen to a 52-week low of $2.18. The 50-Day Moving Average of the stock is -14.82%, while the 200-Day Moving Average is calculated to be -13.37%.
Shares Statistics:
It appears that HIVE traded 9.37M shares on average per day over the past three months and 12264620 shares per day over the past ten days. A total of 129.04M shares are outstanding, with a floating share count of 128.27M. Insiders hold about 0.60% of the company’s shares, while institutions hold 25.04% stake in the company. Shares short for HIVE as of 1736899200 were 4251729 with a Short Ratio of 0.45, compared to 1734048000 on 3500140.
